rs386833807
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_003982.4(SLC7A7):c.1402C>T(p.Arg468*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000155 in 1,614,040 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_003982.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC7A7 | NM_003982.4 | c.1402C>T | p.Arg468* | stop_gained | Exon 9 of 10 | ENST00000674313.1 | NP_003973.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152198Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251412Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135880
GnomAD4 exome AF: 0.0000157 AC: 23AN: 1461842Hom.: 0 Cov.: 33 AF XY: 0.0000124 AC XY: 9AN XY: 727220
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74342
ClinVar
Submissions by phenotype
Lysinuric protein intolerance Pathogenic:7
- -
- -
- -
- -
- -
The stop gained c.1402C>Tp.Arg468Ter variant in SLC7A7 gene has been reported previously in compound heterozygous state in individuals affected with lysinuric protein intolerance Font-Llitjós M, et al., 2009. It has also been observed to segregate with disease in related individuals. The c.1402C>T variant has been reported with allele frequency of 0.002% in gnomAD Exomes and is novel not in any individuals in 1000 Genomes. This variant has been reported to the ClinVar database as Likely Pathogenic / Pathogenic multiple submissions. The nucleotide change c.1402C>T in SLC7A7 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. This sequence change creates a premature translational stop signal p.Arg468Ter in the SLC7A7 gene. This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants have been previously reported to be disease causing. Other variants in the same region p.Arg473* have been previously reported to be pathogenic Habib A,et al., 2016. For these reasons, this variant has been classified as Pathogenic. -
This sequence change creates a premature translational stop signal (p.Arg468*) in the SLC7A7 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 44 amino acid(s) of the SLC7A7 protein. This variant is present in population databases (rs386833807, gnomAD 0.005%). This premature translational stop signal has been observed in individual(s) with lysinuric protein intolerance (PMID: 18716612). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 56359). This variant disrupts a region of the SLC7A7 protein in which other variant(s) (p.Arg473*) have been determined to be pathogenic (PMID: 10655553, 28028301; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
Not observed at significant frequency in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation, as the last 44 amino acids are lost, and other loss-of-function variants have been reported downstream in HGMD; This variant is associated with the following publications: (PMID: 25525159, 18716612, 30665703, 31980526, 29058386, 10655553, 28028301, 37107561) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at